|
Market Closed -
Nasdaq
04:00:00 05/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 220.83 USD | -1.64% |
|
+1.07% | +25.48% |
| 09-04 | Eisai, Biogen Secure China's Nod for Self-Injection Version of Leqembi | MT |
| 09-03 | Piper Sander Adjusts Biogen Price Target to $245 From $225, Maintains Overweight Rating | MT |
| Market Cap | 32.63B 28.1B 26.4B 24.13B 45.15B 3,083B 45.3B 312B 121B 1,580B 123B 120B 5,097B | P/E 2026 * |
38.1x | P/E 2027 * | 19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 37.57B 32.35B 30.39B 27.78B 51.98B 3,550B 52.16B 359B 139B 1,819B 141B 138B 5,868B | EV / Sales 2026 * |
3.6x | EV / Sales 2027 * | 3.29x |
| Free-Float |
85.8% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
Boerse Muenchen
| IDP | Real-time | |
Xetra
| IDP | Delayed | |
Tradegate
| IDP | Real-time | |
Borsa Italiana
| 1BIIB | End-of-day quote | |
Mexican S.E.
| BIIB * | End-of-day quote | |
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
Deutsche Boerse AG
| IDP | Delayed | |
Swiss Exchange
| BIIB | Delayed | |
Wiener Boerse
| BIIB | End-of-day quote | |
Börse Stuttgart
| IDP | Delayed | |
Santiago S.E.
| BIIB | End-of-day quote | |
Santiago S.E.
| BIIBCL | End-of-day quote | |
Swiss Exchange
| BIIB | Delayed |
Last Transcript : Biogen Inc.
| 1 day | -1.64% | ||
| 1 week | +1.07% | ||
| Current month | +1.93% | ||
| 1 month | +5.94% | ||
| 3 months | +12.41% | ||
| 6 months | +16.26% | ||
| Current year | +25.48% |
| 1 week | 213.58 | 225.8 | |
| 1 month | 201 | 225.8 | |
| Current year | 160.36 | 225.8 | |
| 1 year | 135.39 | 225.8 | |
| 3 years | 110.04 | 269.43 | |
| 5 years | 110.04 | 332.87 | |
| 10 years | 110.04 | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Daniel Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 28/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/9/26 | Free | General Counsel | 7,405 | 0.0050% | ||
| 4/8/26 | Sell | Director | -593 | 0.0004% | ||
| 9/6/26 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.64% | +1.07% | +57.80% | -17.34% | 32.63B | ||
| -1.87% | +4.22% | +45.93% | -0.47% | 82.65B | ||
| -0.57% | +1.27% | -17.24% | -34.99% | 60.24B | ||
| -2.23% | +5.48% | +499.46% | +29.31% | 58.11B | ||
| -2.03% | -2.62% | -7.46% | +27.87% | 49.68B | ||
| -4.58% | -2.73% | +2.93% | +157.71% | 46.66B | ||
| -0.98% | +1.91% | +48.35% | +95.93% | 25.69B | ||
| -0.19% | -4.74% | +2.30% | +196.81% | 22.73B | ||
| -1.13% | -2.45% | +65.99% | +110.75% | 16.51B | ||
| +1.94% | -9.84% | -19.78% | +771.20% | 14.92B | ||
| Average | -1.33% | -0.83% | +67.83% | +133.68% | 40.98B | |
| Weighted average by Cap. | -1.72% | +0.49% | +86.67% | +68.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.44B 8.99B 8.45B 7.72B 14.45B 987B 14.5B 99.89B 38.73B 506B 39.22B 38.36B 1,632B | 10.66B 9.18B 8.62B 7.88B 14.74B 1,007B 14.8B 102B 39.51B 516B 40.01B 39.14B 1,665B |
| Net income | 964M 830M 780M 713M 1.33B 91.07B 1.34B 9.22B 3.57B 46.67B 3.62B 3.54B 151B | 1.86B 1.6B 1.5B 1.37B 2.57B 175B 2.58B 17.75B 6.88B 89.85B 6.97B 6.81B 290B |
| Net Debt | 4.94B 4.25B 3.99B 3.65B 6.83B 466B 6.85B 47.22B 18.3B 239B 18.54B 18.13B 771B | 2.42B 2.08B 1.96B 1.79B 3.35B 229B 3.36B 23.15B 8.97B 117B 9.09B 8.89B 378B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$220.83 | -1.64% | 465,108 |
| 03/09/26 | US$224.51 | +0.83% | 550,745 |
| 02/09/26 | US$222.67 | +3.07% | 1,268,282 |
| 01/09/26 | US$216.04 | -0.28% | 785,496 |
| 31/08/26 | US$216.65 | -0.85% | 831,004 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions

















